Interplay Between Gut Microbiota and Cholesterol Metabolism in Colorectal Cancer
International Journal of Molecular Sciences · 10.03.2026 · 27 (6) · 2553
DOI: 10.3390/ijms27062553 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 10.03.2026. Verfasst von Sarah Wing Lam Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Cholesterol, Gastrointestinal Microbiome. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 131 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University Grants Committee, General Research Fund, University Grants Committee, Hong Kong.
Abstract (Originalsprache)
Both gut microbiota dysbiosis and disrupted cholesterol metabolism are associated with colorectal cancer (CRC). While the interactions between these two factors have been well explored in diseases such as cardiovascular disease and atherosclerosis, their interactions and underlying mechanisms in CRC pathogenesis remain insufficiently explored, constituting a critical area for further investigation. This review examines the complex relationship between gut microbiota and cholesterol metabolism in CRC development from 2 perspectives: how specific gut microbial species can increase CRC risk by modulating cholesterol metabolism, particularly through bile acids and oxysterols, and how disrupted cholesterol metabolism can exacerbate microbial dysbiosis and promote CRC. The bidirectional relationship between gut dysbiosis and cholesterol dysregulation creates a vicious cycle that drives CRC development. Moreover, the potential of targeting the gut microbiome and cholesterol metabolism to develop new strategies for preventing and treating CRC is discussed, highlighting the promise of certain bacterial strains that exert protective effects via cholesterol-lowering mechanisms. By elucidating the intricate connections between gut microbiota, cholesterol metabolism, and CRC, this review paves the way for innovative approaches in CRC prevention and therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China.
- Department of Medicine and Therapeutics, Li Ka Shing Institute of Health Sciences, CUHK Shenzhen Research Institute, The Chinese University of Hong Kong, Hong Kong, China.
- Schulich School of Medicine & Dentistry, Western University, London, ON N6A 3K7, Canada.
- Department of Biology, University of Toronto, Mississauga, ON L5L 1C6, Canada.
ORCID-Profile: Adrian Leonard Zaleski, Jessie Qiaoyi Liang
Förderung
- University Grants Committee
- General Research Fund, University Grants Committee, Hong Kong
Zitieren
APA
Li, S. W. L., Au, O. T. H., Lau, E. Y. T., Lu, R. Y., Zaleski, A. L., & Liang, J. Q. (2026). Interplay Between Gut Microbiota and Cholesterol Metabolism in Colorectal Cancer. International Journal of Molecular Sciences, 27(6), 2553. https://doi.org/10.3390/ijms27062553
Vancouver
Li SWL, Au OTH, Lau EYT, Lu RY, Zaleski AL, Liang JQ. Interplay Between Gut Microbiota and Cholesterol Metabolism in Colorectal Cancer. International Journal of Molecular Sciences. 2026;27(6):2553. doi:10.3390/ijms27062553
BibTeX
@article{Li2026,
author = {Li, Sarah Wing Lam and Au, Oscar Ting Hei and Lau, Effie Yin Tung and Lu, Riley Yanjun and Zaleski, Adrian Leonard and Liang, Jessie Qiaoyi},
title = {Interplay Between Gut Microbiota and Cholesterol Metabolism in Colorectal Cancer},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {6},
pages = {2553},
doi = {10.3390/ijms27062553}
}
EUVIMED